Tiera's Dermal Fillers: PLLA & HA Solutions for Clinics

The primary objective of modern dermal filler therapy is to achieve natural looking facial rejuvenation by strategically replacing lost volume and stimulating the body's own collagen production. DERMECA hyaluronic acid dermal fillers are at the forefront of this approach, utilizing a patented cross linking technology that creates a three dimensional network capable of binding water molecules and providing sustained tissue support. This makes them exceptionally suitable for a variety of complex applications, such as restoring volume to the lateral brow for a subtle lifting effect, smoothing perioral rhytids, and augmenting the mandibular angle to create a stronger, more defined jawline. A notable case study involves the correction of post traumatic facial asymmetry, where a tailored injection protocol using different DERMECA formulations successfully restored facial harmony and patient confidence, as validated by standardized photometric analysis. TIERA's commitment to quality is embedded in every production stage, from the sourcing of pharmaceutical grade bacterial fermentation precursors to the final release of the finished product. The facility's adherence to ISO13485 ensures a fully documented and controlled environment, with every material and process variable meticulously tracked. The accompanying clinical data package, developed under CFDA mirrored protocols, provides healthcare professionals with the necessary evidence to make informed decisions, detailing outcomes related to product longevity, patient satisfaction, and adverse event profiles. For global clients, TIERA's experience in exporting to diverse climates and regulatory zones, including the United States, South Africa, and the Middle East, ensures that products are stable and compliant upon arrival. The OEM program is a key offering, allowing for the creation of proprietary products that may feature unique delivery systems, such as integrated needle syringe combinations or specific concentrations of hyaluronic acid. For further details on our product portfolio's clinical applications, to request the full clinical study report, or to explore OEM possibilities, please contact our customer service center to be connected with a technical specialist.